Their findings showed that the combination of G47Δ⁃mIL⁃12 and ICIs could eradicate glioma in two mouse models, which was associated with T cell activation, an influx of tumor-associated macrophages (TAMs) and M1-like polarization, along with increased T effector to T regulatory ratio. This evidence concerns the gene SPRR2A and glioma.